Nouveau Life Pharmaceuticals, Inc. (NOUV)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
At close: Feb 12, 2026

NOUV Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2007FY 2006FY 2005FY 2004FY 2003
Period Ending
Mar '08 Jun '07 Jun '06 Jun '05 Jun '04 Jun '03
Net Income
-0.5-0.36-0.26-0.4-0.31-0.25
Depreciation & Amortization
0.240.11----
Stock-Based Compensation
00.030.030.030.010.15
Other Operating Activities
0.10.10.120.250.20.07
Change in Accounts Payable
0.10.080.020.060.020.02
Change in Other Net Operating Assets
0.030.02----
Operating Cash Flow
-0.02-0.02-0.08-0.06-0.08-0.01
Capital Expenditures
-0-----
Investing Cash Flow
-0-----
Short-Term Debt Issued
-00.01-0.010
Long-Term Debt Issued
----0-
Total Debt Issued
000.01-0.010
Long-Term Debt Repaid
--0----
Total Debt Repaid
-0.01-0----
Net Debt Issued (Repaid)
-0.0100.01-0.010
Issuance of Common Stock
0.020.020.080.060.080.01
Other Financing Activities
----0--
Financing Cash Flow
0.020.020.080.060.090.01
Foreign Exchange Rate Adjustments
000--0
Net Cash Flow
-000-0.010.01-0
Free Cash Flow
-0.02-0.02-0.08-0.06-0.08-0.01
Free Cash Flow Per Share
-0.00-0.00-0.00-0.00-0.00-0.00
Cash Interest Paid
00----
Levered Free Cash Flow
0.10.070.08-0.34-0.090.02
Unlevered Free Cash Flow
0.150.120.13-0.29-0.040.06
Change in Working Capital
0.130.090.020.060.020.02
Source: S&P Global Market Intelligence. Standard template. Financial Sources.